| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Dawson Bruce Neil | Chief Sales and CS Officer | C/O IBEX LIMITED, 1717 PENNSYLVANIA AVENUE NW, SUITE 825, WASHINGTON | Lisa Lenstrohm, Attorney-in-Fact | 16 May 2025 | 0001973708 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IBEX | Common Shares | Options Exercise | $127,500 | +10,000 | +178% | $12.75 | 15,607 | 05 Mar 2025 | Direct | |
| transaction | IBEX | Common Shares | Sale | $244,800 | -10,000 | -64% | $24.48 | 5,607 | 05 Mar 2025 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IBEX | Stock Option (Right to Buy Common Shares) | Options Exercise | $0 | -10,000 | -100% | $0.000000 | 0 | 05 Mar 2025 | Common Shares | 10,000 | $12.75 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | The shares subject to this option are fully vested and exercisable. |